Browsing by Author "Juan P. Nogueira"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Association between lipid markers in childhood/ adolescence and cardiovascular events in adulthood: A systematic review(2023-01-07) Walter Masson; Leandro Barbagelata; Pablo Corral; Juan P. NogueiraThis systematic review evaluated the association between lipid markers in childhood and adolescence and cardiovascular events in adulthood. Following PRISMA guidelines, prospective observational cohort studies assessing childhood lipid levels and subsequent cardiovascular outcomes were included. Five studies involving 43,540 participants met the eligibility criteria. Elevated triglyceride levels were consistently associated with increased cardiovascular risk in adulthood. Total cholesterol and lipoprotein(a) also showed significant predictive associations, while findings for LDL-C were heterogeneous and HDL-C showed no significant association. These findings suggest that lipid abnormalities during childhood and adolescence may predict cardiovascular disease in early and middle adulthood, supporting early lipid screening and cardiovascular risk assessment.Item Dyslipidemia in adults with congenital heart disease: A systematic review and meta-analysis(2023-07-12) Walter Masson; Leandro Barbagelata; Martín Lobo; Pablo Corral; Juan P. Nogueira; Luciano LucasThis systematic review and meta-analysis evaluated dyslipidemia prevalence and lipid levels in adults with congenital heart disease. Following PRISMA guidelines, observational studies reporting dyslipidemia prevalence or comparing lipid profiles between congenital heart disease patients and controls were included. Twenty-nine studies involving 22,914 patients and 641,086 controls were analyzed. Reported dyslipidemia prevalence ranged from 14.3% to 69.9%. Quantitative analysis showed significantly lower total cholesterol, LDL-C, and HDL-C levels in patients with congenital heart disease compared with controls, while triglyceride levels showed no significant differences. Further research using standardized dyslipidemia definitions and accounting for disease complexity and confounding factors is warranted.